NuCana plc (NCNA)
NASDAQ: NCNA · Real-Time Price · USD
3.260
-0.050 (-1.51%)
Dec 24, 2025, 9:36 AM EST - Market open
NuCana Market Cap
NuCana has a market cap or net worth of $13.57 million as of December 24, 2025. Its market cap has increased by 155.99% in one year.
Market Cap
13.57M
Enterprise Value
-19.98M
1-Year Change
155.99%
Ranking
Category
Stock Price
$3.26
Market Cap Chart
Since September 28, 2017, NuCana's market cap has decreased from $513.70M to $13.57M, a decrease of -97.36%. That is a compound annual growth rate of -35.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 23, 2025 | 13.80M | 193.62% |
| Dec 31, 2024 | 4.70M | -69.87% |
| Dec 29, 2023 | 15.60M | -54.65% |
| Dec 30, 2022 | 34.40M | -72.30% |
| Dec 31, 2021 | 124.20M | -21.19% |
| Dec 31, 2020 | 157.60M | -19.84% |
| Dec 31, 2019 | 196.60M | -57.38% |
| Dec 31, 2018 | 461.30M | 43.44% |
| Dec 29, 2017 | 321.60M | -37.40% |
| Sep 28, 2017 | 513.70M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 959.53B |
| Johnson & Johnson | 495.78B |
| AbbVie | 404.36B |
| UnitedHealth Group | 294.22B |
| AstraZeneca | 287.19B |
| Novartis AG | 267.64B |
| Merck & Co. | 260.71B |
| Novo Nordisk | 232.28B |